Scilex Holding Co
SCLXW- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001820190
No open-market purchases or sales by Scilex Holding Co insiders were filed in the last 90 days; 5 institutions reported holding it in 13F filings for Q2 2026, worth $16.4K in total; no superinvestor holds it.
Other share classesSCLX
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Scilex Holding Co insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Scilex Holding Co, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| SCLX Stock Acquisition JV LLC | 10% Owner | 958,263 | Jul 7, 2026 | 1 |
| Ma Stephen Hoi | CFO, COO and Secretary | 22,840 | Apr 20, 2026 | 2 |
| Ji Henry | Exec Chair, CEO and President | 320,161 | Apr 20, 2026 | 2 |
| Scilex Holding Co | 10% Owner | 244,445,260 | Dec 30, 2025 | 1 |
| Wu Yue Alexander | Director | 25,000 | Oct 9, 2025 | 1 |
| Followwill Dorman | Director | 2,300 | Oct 9, 2025 | 1 |
| Chun Jay | Director | 112,500 | Oct 9, 2025 | 1 |
| Shah Jaisim | See Remarks | 139,333 | Dec 18, 2024 | 0 |
| Lemus David | Director | 2,000 | Oct 18, 2024 | 0 |
| Navani Annu | Director | – | Aug 19, 2024 | 0 |
| Sorrento Therapeutics, Inc. | 10% Owner | 1,917,210 | Sep 25, 2023 | 0 |
| Czerepak Elizabeth | See Remarks | – | Jan 17, 2023 | 0 |
| Thompson Tommy G | Director | – | Jan 17, 2023 | 0 |
| Hamill Laura | Director | – | Jan 17, 2023 | 0 |
| Lee Tien-Li | Director | – | Jan 17, 2023 | 0 |
| Ho Chris | Other: See footnote (1) | – | Nov 15, 2022 | 0 |
| Vickers Venture Fund VI (Plan) Pte Ltd | Other: See footnote (1) | – | Nov 15, 2022 | 0 |
| Vickers Venture Fund VI Pte Ltd | 10% Owner, Other: See footnote (1) | – | Nov 15, 2022 | 0 |
| Chi Jeffrey | Other: See footnote (1) | – | Nov 15, 2022 | 0 |
| Kaji Suneel G | Director, Other: See Remarks | – | Nov 15, 2022 | 0 |
| Myint Steve | Director, Other: See Remarks | – | Nov 15, 2022 | 0 |
| Woo Pei Wei | Director, Other: See Remarks | – | Nov 15, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 20, 2026 (view filing)8:56 AM ET | Apr 17 | 3 days | Ma Stephen HoiCFO, COO and Secretary | PPurchase | +650.0K | $0.1538 | +$100.0K | –650.0K after | Derivative |
| Apr 20, 2026 (view filing)8:52 AM ET | Apr 16 | 4 days | Ji HenryExec Chair, CEO and President | PPurchase | +3.25M | $0.1538 | +$499.9K | –3.25M after | Derivative |
| Apr 20, 2026 (view filing)8:52 AM ET | Apr 17 | 3 days | Ji HenryExec Chair, CEO and President | SSale | −650.0K | $0.1538 | −$100.0K | –2.60M after | Derivative |
| Dec 30, 2025 (view filing) | Dec 26-30 | 4 days | Scilex Holding Co10% Owner | SSale | −20.7M | $0.62 | −$12.8M | −7.8%244.4M after | 3 lots |
| Dec 18, 2024 (view filing)7:04 PM ET | Dec 18 | Same day | Shah JaisimSee Remarks | PPurchase | +30.0K | $0.46 | +$13.8K | +27.4%139.3K after | |
| Oct 31, 2024 (view filing) | Oct 31 | Same day | Ji HenryExecutive Chairperson | PPurchase | +8.89K | $0.94 | +$8.35K | +2.9%320.2K after | |
| Oct 29, 2024 (view filing) | Oct 29 | Same day | Shah JaisimSee Remarks | PPurchase | +32.0K | $0.99 | +$31.7K | +41.4%109.3K after | |
| Oct 18, 2024 (view filing) | Oct 18 | Same day | Followwill DormanDirector | PPurchase | +1.00K | $0.99 | +$990 | +76.9%2.30K after | |
| Oct 18, 2024 (view filing) | Oct 18 | Same day | Chun JayDirector | PPurchase | +5.00K | $0.95 | +$4.75K | +4.7%112.5K after | |
| Oct 18, 2024 (view filing) | Oct 17 | 1 day | Wu Yue AlexanderDirector | PPurchase | +20.0K | $0.95 | +$19.0K | +400.0%25.0K after | |
| Oct 18, 2024 (view filing) | Oct 17 | 1 day | Lemus DavidDirector | PPurchase | +2.00K | $0.90 | +$1.80K | New position2.00K after | |
| Oct 18, 2024 (view filing) | Oct 17 | 1 day | Ji HenryExecutive Chairperson | PPurchase | +10.0K | $0.97 | +$9.70K | +20.0%60.1K after | |
| Oct 17, 2024 (view filing) | Oct 16 | 1 day | Shah JaisimSee Remarks | PPurchase | +30.0K | $0.99 | +$29.7K | +63.4%77.3K after | |
| Oct 17, 2024 (view filing) | Oct 16 | 1 day | Ma Stephen HoiChief Financial Officer | PPurchase | +6.70K | $0.97 | +$6.50K | +41.5%22.8K after | |
| May 17, 2024 (view filing) | May 17 | Same day | Ji HenryExecutive Chairperson | PPurchase | +50.0K | $0.88 | +$44.0K | +71,428.6%50.1K after | |
| May 17, 2024 (view filing) | May 17 | Same day | Chun JayDirector | PPurchase | +57.5K | $0.90 | +$51.8K | +127.8%102.5K after | |
| May 17, 2024 (view filing) | May 16-17 | 1 day | Shah JaisimSee Remarks | PPurchase | +140.0K | $0.8725 | +$122.2K | +881.5%155.9K after | 2 lots |
| May 17, 2024 (view filing) | May 17 | Same day | Ma Stephen HoiChief Financial Officer | PPurchase | +14.1K | $0.88 | +$12.4K | New position14.1K after | |
| Sep 25, 2023 (view filing) | Sep 21 | 4 days | Sorrento Therapeutics, Inc.10% Owner | SSale | −60.1M | – | – | −96.9%1.92M after | |
| Sep 25, 2023 (view filing) | Sep 21 | 4 days | Sorrento Therapeutics, Inc.10% Owner | SSale | −4.49M | – | – | –0 after | Derivative |
| Dec 2, 2022 (view filing)7:21 PM ET | Dec 2 | Same day | Sorrento Therapeutics, Inc.10% Owner | PPurchase | +224.8K | $0.3507 | +$78.9K | –4.49M after | Derivative |
| Nov 25, 2022 (view filing)3:21 PM ET | Nov 25 | Same day | Sorrento Therapeutics, Inc.10% Owner | PPurchase | +46.2K | $0.4374 | +$20.2K | –4.27M after | Derivative |
| Nov 23, 2022 (view filing)5:59 PM ET | Nov 23 | Same day | Sorrento Therapeutics, Inc.10% Owner | PPurchase | +442.8K | $0.3967 | +$175.7K | –4.22M after | Derivative |
| Nov 22, 2022 (view filing)7:24 PM ET | Nov 22 | Same day | Sorrento Therapeutics, Inc.10% Owner | PPurchase | +672.8K | $0.226 | +$152.0K | –3.78M after | Derivative |